Identification and Characterization of Oxidative Metabolites of 1‑Chloropyrene

• Published in: Chemical research in toxicology Vol. 28; no. 9; pp. 1728 - 1736
• Main Authors: Kakimoto, Kensaku, Nagayoshi, Haruna, Inazumi, Naoya, Tani, Atsushi, Konishi, Yoshimasa, Kajimura, Keiji, Ohura, Takeshi, Nakano, Takeshi, Tang, Ning, Hayakawa, Kazuichi, Toriba, Akira
• Format: Journal Article
• Language: English
• Published: WASHINGTON American Chemical Society 21.09.2015; Amer Chemical Soc
• Subjects: Chemistry; Chemistry, Medicinal; Chemistry, Multidisciplinary; Chromatography, Liquid; Humans; Life Sciences & Biomedicine; Ligands; Magnetic Resonance Spectroscopy; Oxidation-Reduction; Pharmacology & Pharmacy; Physical Sciences; Pyrenes - metabolism; Pyrenes - urine; Receptors, Aryl Hydrocarbon - metabolism; Science & Technology; Tandem Mass Spectrometry; Toxicology; PYRENE; LIQUID-CHROMATOGRAPHY; POLYCYCLIC AROMATIC-HYDROCARBONS; CHINA; 1-HYDROXYPYRENE; PARENT; HUMAN URINE; ENVIRONMENTAL-SAMPLES; MASS-SPECTROMETRY; EXPOSURE
• ISSN: 0893-228X; 1520-5010
• DOI: 10.1021/acs.chemrestox.5b00173

Polycyclic aromatic hydrocarbons (PAHs) and chlorinated PAHs (ClPAHs) are ubiquitous contaminants that bind to the aryl hydrocarbon receptor (AhR) and exhibit mutagenic potential. It is difficult to monitor human exposure levels to ClPAHs because the exposure routes are complicated, and environmental concentrations are not always correlated with the levels of PAHs. Urinary PAH metabolites are useful biomarkers for evaluating PAH exposure, and ClPAH metabolites may therefore contribute to the estimation of ClPAH exposure. One of the most abundant ClPAHs present in the environment is 1-chloropyrene (ClPyr), and urinary ClPyr metabolites have the potential to be good biomarkers to evaluate the level of exposure to ClPAHs. Since the metabolic pathways involving ClPAHs are still undetermined, we investigated the effect of human cytochrome P450 enzymes on ClPyr and identified three oxidative metabolites by liquid chromatography–tandem mass spectrometry and nuclear magnetic resonance. We found that ClPyr was metabolized most efficiently by the P450 1A1 enzyme, followed by the 1B1 and 1A2 enzymes. Similar to ClPyr, these metabolites were shown to have agonist activity for the human AhR. We detected these metabolites when ClPyr reacted with a pooled human liver S9 fraction as well as in human urine samples. These results suggest that the metabolites may be used as biomarkers to evaluate the extent of exposure to ClPAHs.